Search results
Results from the WOW.Com Content Network
James D. Griffin is an American physician-scientist. He is currently Professor of Medicine at Harvard Medical School, Chair of Medical Oncology at Dana–Farber Cancer Institute, and Director of Medical Oncology at Brigham and Women's Hospital.
In 2014, Freeman received the William B. Coley Award along with Tasuku Honjo, Lieping Chen and Arlene Sharpe. [3]In 2017, Freeman was one of the winners of the Warren Alpert Foundation Prize, and in 2022 he was elected to the American Academy of Arts and Sciences and the National Academy of Sciences.
Dana–Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts.Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
Mary-Ellen Taplin (born 1960), is a research oncologist at Dana Farber Cancer Institute and Brigham and Women's Hospital in Harvard's Longwood Medical and Academic Area. Taplin is Institute Physician and Director of Clinical Research for the Lank Center for Genitourinary Oncology at Dana Farber Cancer Institute and at the Brigham and Women's ...
Subsequently she trained at the University of California, San Francisco and Dana–Farber Cancer Institute. In 2007, she received a masters in public health from Harvard University . [ 1 ] [ 2 ] As of 2021, Ng is a physician at the Dana–Farber Cancer Institute and a professor at Harvard Medical School . [ 3 ]
Todd Golub, class of 1989, Professor of Pediatrics at the Harvard Medical School, the Charles A. Dana Investigator in Human Cancer Genetics at the Dana-Farber Cancer Institute, and a founding member of the Broad Institute of MIT and Harvard. Clarence Lushbaugh, Ph.D. class of 1942, M.D. class of 1948, pathologist and radiobiological specialist
In 2000, Wu joined the Dana-Farber faculty and began her independent research program in 2005. [1]In 2011, Wu was the recipient of a Stand Up To Cancer Innovative Research Grant for her project "Coupled Genetic and Functional Dissection of Chronic Lymphocytic Leukemia."
In July 2015, Haas-Kogan succeeded Jay Harris as Chair of the Department of Radiation Oncology at the Dana–Farber Cancer Institute, Brigham and Women’s Hospital (BWHC), and Boston Children’s Hospital. She was also appointed professor at Harvard Medical School and become an endowed professor of Radiation Oncology at BWHC. [3]